Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel T Chang

Showing results (191-200 of 224) with videos related to

Pageof 23
Sort By:
Advances in Radiation Oncology|June 12, 2025
Sequential <sup>90</sup>Y Selective Internal Radiation Therapy (SIRT) and Stereotactic Body Radiation Therapy (SBRT) using <sup>90</sup>Y PET-based Absorbed Dose Maps: Interim Analysis of a Phase 1 StudyDaniel F Polan, Justin K Mikell, Kellen Fitzpatrick, et al.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2014
Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapyAvani S Dholakia, Muhammad Chaudhry, Jeffrey P Leal, et al.
Practical Radiation Oncology|August 25, 2016
Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancerAvani D Rao, Elizabeth A Sugar, Daniel T Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancerDevin Schellenberg, Jeff Kim, Claudia Christman-Skieller, et al.
Journal of the National Cancer Institute|December 3, 2024
Increased occurrence of malignancy before and after chemoradiation for anal squamous cell carcinoma: a multi-institutional analysisRitesh Kumar, Chris L Hallemeier, Daniel T Chang, et al.
Practical Radiation Oncology|April 15, 2026
A Case-Based Guide: Demonstrating the ReCOG Consensus for Dosimetric Assessment and Reporting in ReirradiationClaire Zhang, Charles S Mayo, Charles K Matrosic, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutionsAaron T Wild, Susan M Hiniker, Daniel T Chang, et al.
Practical Radiation Oncology|October 24, 2020
Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice GuidelineJennifer Y Wo, Christopher J Anker, Jonathan B Ashman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2025
Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): Two-Year primary outcome analysisDaniella Klebaner, Eleanor Brown, George A Fisher, et al.
Cancer Cell|October 11, 2017
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic CancerStephano S Mello, Liz J Valente, Nitin Raj, et al.
Pageof 23

Showing results (191-200 of 224) with videos related to

Sort By:
Pageof 23
Advances in Radiation Oncology|June 12, 2025
Sequential <sup>90</sup>Y Selective Internal Radiation Therapy (SIRT) and Stereotactic Body Radiation Therapy (SBRT) using <sup>90</sup>Y PET-based Absorbed Dose Maps: Interim Analysis of a Phase 1 StudyDaniel F Polan, Justin K Mikell, Kellen Fitzpatrick, et al.
International Journal of Radiation Oncology, Biology, Physics|April 23, 2014
Baseline metabolic tumor volume and total lesion glycolysis are associated with survival outcomes in patients with locally advanced pancreatic cancer receiving stereotactic body radiation therapyAvani S Dholakia, Muhammad Chaudhry, Jeffrey P Leal, et al.
Practical Radiation Oncology|August 25, 2016
Patient-reported outcomes of a multicenter phase 2 study investigating gemcitabine and stereotactic body radiation therapy in locally advanced pancreatic cancerAvani D Rao, Elizabeth A Sugar, Daniel T Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancerDevin Schellenberg, Jeff Kim, Claudia Christman-Skieller, et al.
Journal of the National Cancer Institute|December 3, 2024
Increased occurrence of malignancy before and after chemoradiation for anal squamous cell carcinoma: a multi-institutional analysisRitesh Kumar, Chris L Hallemeier, Daniel T Chang, et al.
Practical Radiation Oncology|April 15, 2026
A Case-Based Guide: Demonstrating the ReCOG Consensus for Dosimetric Assessment and Reporting in ReirradiationClaire Zhang, Charles S Mayo, Charles K Matrosic, et al.
Journal of Gastrointestinal Oncology|December 3, 2013
Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutionsAaron T Wild, Susan M Hiniker, Daniel T Chang, et al.
Practical Radiation Oncology|October 24, 2020
Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice GuidelineJennifer Y Wo, Christopher J Anker, Jonathan B Ashman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2025
Phase II trial of organ preservation program using short-course radiation and FOLFOXIRI for rectal cancer (SHORT-FOX): Two-Year primary outcome analysisDaniella Klebaner, Eleanor Brown, George A Fisher, et al.
Cancer Cell|October 11, 2017
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic CancerStephano S Mello, Liz J Valente, Nitin Raj, et al.
Pageof 23